Blood pressure and glucose control in subjects with diabetes: New analyses from ADVANCE

Journal of Hypertension

Volumn 27, Issue SUPPL. 1, 2009, Pages

  Poulter, Neil R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Gliclazide MR; Glucose; Perindopril indapamide combination; Type 2 diabetes

Indexed keywords

GLICLAZIDE; HEMOGLOBIN A1C; INDAPAMIDE PLUS PERINDOPRIL; PLACEBO; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; REVIEW; STROKE; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED;

EID: 68049124872     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000354417.70192.be     Document Type: Review

References (11)

1. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society, 1999. J Human Hypertens 1999; 13:569-592.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Prevention, detection, evaluation, and treatment of high blood pressure (JNC 7). J Hypertens 2003; 42:1206-1252.
3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice guidelines for the management of arterial hypertension. ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762. (Pubitemid 47356612)
4. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med 2005; 165:1410-1419.
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352:854-865.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the years 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053. (Pubitemid 38579764)
7. ADVANCE Management Committee. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation. J Hypertens 2001 (Suppl. 4) 19:S21-S28.
8. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular outcomes in patients with type 2 diabetes mellitus: results of the blood pressure lowering arm of the ADVANCE trial. Lancet 2007; 370:829-840.
9. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
10. Perkovic V, Ninomiya T, de Galan BE, Zoungas S, Cass A, Patel A, et al. Joint effects of routine blood pressure lowering and intensive glucose control in the ADVANCE Trial. Clin J Am Soc Nephrol 2008; 3:RB01-RB04.
11. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559.